Products

EMARKETER delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
PRO+
New data sets, deeper insights, and flexible data visualizations.
Learn More
Reports
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Forecasts
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Charts
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Briefings
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About EMARKETER

Our goal is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Events
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Podcasts
Tune in to EMARKETER's daily, weekly, and monthly podcasts.
Learn More

Cigna reportedly wants to buy Centene—but we think the multi-billion dollar deal won’t happen

The news: Cigna has reportedly shown interest in buying fellow insurer Centene over the last few months, per Bloomberg. The deal discussions were reported preliminary and didn’t lead to serious negotiations, and it’s unclear whether or not the talks will be restarted anytime soon.

What a Centene merger could mean for Cigna: Combined, the duo would create a Medicaid and Medicare behemoth, rivaling insurance giants like United Healthcare (UHC).

  • Cigna would reach millions of Medicaid patients with Centene under its roof. Centene’s primary business is Medicaid: It covers over 26 million managed care members (1 in 15 individuals across the US), according to its website.
  • This would complement Cigna’s already massive existing member base: Cigna claims it serves over 180 million customer and patient relationships globally across its pharmacy (Express Scripts) and medical business, many of which are US-based Medicare members.

Plus, Cigna would become a much larger threat to market leader United Healthcare.

  • For context, UnitedHealth Group (UHG) holds the highest market share (15%) among all insurers, per a 2021 AMA report.
  • Cigna trails behind UHG in market share at 12%, but by adding Centene into the mix (2%), it would be inching closer to UHG’s top spot.

But… We don’t think it's likely Cigna will acquire Centene anytime soon considering the FTC’s crackdown of insurer M&A deals over the past few years.

Large mergers usually take significant time to close due to antitrust regulatory barriers:

  • For example, UHG and health IT giant Change Healthcare announced their merger over a year ago, but the duo still has to earn approval from the federal government before the deal can be marked complete.

Plus, the federal government has shut down large insurer M&As in the past, which means a Cigna-Centene merger could see the same fate:

  • In 2017, a federal judge blocked insurer Anthem’s $52 billion acquisition of Cigna since the two giants combined would create the largest health insurance conglomerate in the US—and make it more difficult for employers to get fair rates for health plans.
  • And during the same year, Aetna and Humana called off their multi-billion dollar M&A merger after a federal judge blocked the deal since it would have substantially decreased competition in the health insurance industry.